Fig. 16
From: In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents
Binding mode of five most active compounds (12, 16, N9, W20 and Z24) into the CDK-8 active site
Fig. 16 | BMC Chemistry